[1] Lachmann G,La Rosée P,Schenk T,et al.Hämophagozytische Lymphohistiozytose : Diagnostische Herausforderung auf der ITS [Hemophagocytic lymphohistiocytosis: A diagnostic challenge on the ICU[J]. Anaesthesist,2016,65(10):776-786. [2] Henter J I,Horne A,Aricó M,et al.HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J]. Pediatr Blood Cancer,2007, 48(2):124-131. [3] Parikh S A,Kapoor P,Letendre L,et al.Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis[J]. Mayo Clinic Proc,2014,89(4): 484-492. [4] Arca M,Fardet L,Galicier L,et al.Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide[J]. Br J Haematol,2015,168(1): 63-68. [5] Hayden A,Park S,Giustini D,et al.Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review[J]. Blood Rev,2016,30(6):411-420. [6] Usmani G N,Woda B A,Newburger P E.Advances in understanding the pathogenesis of HLH[J]. Br J Haematol,2013,161(5):609-622. [7] Otrock Z K,Grossman B J,Eby C S.Transfusion requirements and 30-day mortality predictors for adult hemophagocytic lymphohistiocytosis[J]. Int J Hematol,2018,108(5):485-490. [8] Muszynski J A,Spinella P C,Cholette J M,et al.Transfusion-related immunomodulation: review of the literature and implications for pediatric critical illness[J]. Transfusion,2017,57(1):195-206. [9] Sadeghi A,Belali S,Ali Asgari A,et al.Inappropriate packed RBC transfusion in a tertiary care center[J]. Arch Iran Med,2017,20(2):83-85. [10] Wendelbo Ø,Opheim E N,Hervig T,et al.Cytokine profiling and post-transfusion haemoglobin increment in patients with haematological diseases[J]. Vox Sang, 2018,113(7):657-668. [11] Maier C L,Stanworth S J,Sola-Visner M,et al.Prophylactic platelet transfusion: is there evidence of benefit,harm,or No effect?[J]. Transfus Med Rev,2023, 37(4):150751. [12] Reizine F,Le Marec S,Le Meur A,et al.Prophylactic platelet transfusion response in critically ill patients: a prospective multicentre observational study[J]. Crit Care,2023,27(1):373. [13] Griffin G,Shenoi S,Hughes G C.Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy[J]. Best Pract Res Clin Rheumatol, 2020,34(4):101515. [14] Esteban Y M,de Jong J L O,Tesher M S. An overview of hemophagocytic lymphohistiocytosis[J]. Pediatr Ann, 2017,46(8):e309-e313. [15] Janka G E,Lehmberg K.Hemophagocytic lymphohistiocytosis: pathogenesis and treatment[J]. Hematology,2013,2013(1):605-611. [16] Garraud O, Hamzeh-Cognasse H, Laradi S, Pozzetto B, Cognasse F.[Blood transfusion and inflammation as of yesterday, today and tomorrow]. Transfus Clin Biol. 2015,22(3):168-177. [17] Chen B Z,Xia R.Pro-inflammatory effects after platelet transfusion: a review[J]. Vox Sang,2020,115(5):349-357. [18] Lee S,Salehi I,Chary M,et al.“Irony” of managing refractory anemia with transfusional support in hemophagocytic lymphohistiocytosis[J]. Transfus Apher Sci,2016,55(1):105-108. [19] Wang Y R,Qiu Y N,Bai Y,et al.A retrospective analysis of 56 children with hemophagocytic lymphohistiocytosis[J]. JBM,2016,7:227-231. [20] Mahlaoui N,Ouachée-Chardin M,de Saint Basile G,et al. Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients[J]. Pediatrics,2007,120(3):e622-e628. [21] Freeman B,Rathore M H,Salman E,et al.Intravenously administered immune globulin for the treatment of infection-associated hemophagocytic syndrome[J]. J Pediatr,1993,123(3):479-481. [22] Rajagopala S,Singh N,Agarwal R,et al.Severe hemophagocytic lymphohistiocytosis in adults-experience from an intensive care unit from North India[J]. Indian J Crit Care Med,2012,16(4):198-203. [23] Valade S,Joly B S,Veyradier A,et al.Coagulation disorders in patients with severe hemophagocytic lymphohistiocytosis[J]. PLoS One,2021,16(8):e0251216. [24] Li X,Yan H P,Zhang X P,et al.Clinical profiles and risk factors of 7-day and 30-day mortality among 160 pediatric patients with hemophagocytic lymphohistiocytosis[J]. Orphanet J Rare Dis,2020,15(1):229. [25] Kitazawa Y,Saito F,Nomura S,et al.A case of hemophagocytic lymphohistiocytosis after the primary Epstein-Barr virus infection[J]. Clin Appl Thromb Hemost,2007,13(3):323-328. [26] Song Z Q,Tu D Y,Tang G S,et al.Hemophagocytic lymphohistiocytosis and disseminated intravascular coagulation are underestimated,but fatal adverse events in chimeric antigen receptor T-cell therapy[J]. Haematologica, 2023,108(8):2067-2079. |